MRI and Astellas Alliance to Boost Japanese Drug Discovery Startups
Japan-based Mitsubishi Research Institute, Inc. (MRI) and Astellas Pharma Inc. (TYO: 4503) announced the signing...
MSD Wins NMPA Approval for Keytruda-Lenvima Combo in Hepatocellular Carcinoma
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced that China’s National Medical Products Administration...
Xuanzhu Biopharma Files for Hong Kong IPO to Advance Innovative Drug Pipeline
Xuanzhu Biopharmaceutical Co., Ltd., a subsidiary of China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460),...
Roche Imposes New Dosing Restrictions on Elevidys for Non-Ambulatory DMD Patients
Swiss pharmaceutical giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced immediate new dosing restrictions for...
Innovent Biologics Initiates Phase III Trial for Mazdutide in OSA and Obesity
China-based Innovent Biologics, Inc. (HKG: 1801) announced the dosing of the first participant in China...
Abbisko Therapeutics Launches Clinical Study of FGFR4 Inhibitor in Advanced Hepatocellular Carcinoma
Shanghai-based Abbisko Therapeutics Co., Ltd. (HKG: 2256) announced the dosing of the first patient in...
Dessight Biomedical Secures RMB 100M Series A Funding for Surgical Robot Development
Hangzhou-based Dessight Biomedical, a provider of ultra-microsurgery precision solutions, has completed a Series A funding...
AstraZeneca Launches Truqap in China for PIK3CA/AKT1/PTEN-Altered Breast Cancer
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) announced the official commercial launch of Truqap (capivasertib) in...
CR Sanjiu Partners with HELP Therapeutics to Advance iPSC-based Heart Failure Therapy
China-based CR Sanjiu (SHE: 000999), a state-owned pharmaceutical company, announced a partnership with Nanjing-based HELP...
Raffles Medical Partners with CQMU First Hospital to Enhance Healthcare Services
Singapore-based Raffles Medical Group, a leading integrated healthcare provider with a broad presence in Asia,...
AstraZeneca and CSPC Pharma Collaborate on Novel Oral Drug Discovery
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) and China’s CSPC Pharmaceutical Group Ltd (HKG: 1093)...
CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments
China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for...
Cloudbreak Pharma Files for Hong Kong IPO Amid Ophthalmic Drug Development
Cloudbreak Pharma Inc. has submitted another initial public offering (IPO) filing to the Hong Kong...
Nona Biosciences Licenses HCAb Technology to Visterra for Biologic Development
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), announced a licensing agreement with...
BioNTech in Deal to Acquire CureVac for $1.25B to Boost Cancer mRNA Therapies
Germany-based BioNTech SE (NASDAQ: BNTX) announced plans to acquire all outstanding shares of fellow German...
AbbVie’s Mavyret Gains FDA Approval for Acute HCV in Children and Adults
US-based AbbVie (NYSE: ABBV) announced that the US Food and Drug Administration (FDA) has approved...
Zhaoke Ophthalmology’s TAB014 Receives BLA Review for wAMD Treatment
China-based Zhaoke Ophthalmology Ltd (HKG: 6622) announced that its Biologic License Application (BLA) for TAB014,...
GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries
UK-based GSK plc (NYSE: GSK) announced a licensing agreement with Bharat Biotech International Limited, an...
Merck Launches Phase III Trial for Quadrivalent Dengue Vaccine V181
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced the launch of the Phase III...
NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery
US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo...